Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple ...

A Philadelphia Court of Common Pleas jury is slated to hear opening arguments on Tuesday in a case claiming that a ...

Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...

Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...

Sustained use of GLP-1 therapies (a class of medications used to manage Type-2 diabetes) can significantly reduce medical ...

A nurse from Medway battling ovarian cancer who recently outlined her bucket list to Boston 25 News received the ultimate ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands ...

A woman battling ovarian cancer got the surprise of a lifetime when Patriots owner Robert Kraft presented her with tickets to ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

A woman battling ovarian cancer got the surprise of a lifetime when the team presented her with tickets to the Super Bowl.

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...

We’re starting to understand more that endometrial cancer harbors a number of cell surface markers, including folate receptor ...